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Background
The current BNP immunoassay cross-reacts with glycosy-
lated proBNP, and the NT-proBNP assay underestimates
glycosylated NT-proBNP. In addition, the recently devel-
oped high performance dialyzer removes medium-sized
molecular solutes such as b2-microgloburin. We therefore
investigated the effects of high performance dialysis on
measured levels of glycosylated proBNP, glycosylated NT-
proBNP and other BNP-related peptides in end-stage
renal disease (ESRD) patients on hemodialysis.
Method
We used our newly developed immunoassay to measure
plasma total BNP, proBNP and mature BNP in 36 ESRD
patients before and after hemodialysis. Plasma glycosy-
lated NT-proBNP and nonglycosylated NT-proBNP
were measured using Elecsys II after treatment with the
deglycosylating enzymes neuramoinidase and O-glycosy-
dase. We also measured plasma ANP and cGMP using
radioimmunoassays.
Results
Total BNP (-38.9%), proBNP (-29.7%), mature BNP
(-54%), glycosylated NT-proBNP(-45.5%), nonglycosylated
NT-proBNP(-53.4%), ANP(-50.4%) and cGMP(-72.1%)
were all significantly reduced after hemodialysis. The rela-
tive magnitudes of the reductions did not correlate with
any indices of plasma volume, but instead appeared to be
molecular weight dependent. The proBNP/total BNP and
glycosylated NT-proBNP/nonglycosylated NT-proBNP
ratios were increased after hemodialysis. The proBNP/
total BNP ratio correlated positively with hemodialysis vin-
tage and negatively with left atrial diameter and systolic
blood pressure, whereas glycosylated/nonglycosylated
NT-proBNP ratios correlated positively with parathyroid
hormone levels.
Conclusion
These results suggest that plasma BNP and its related pep-
tides measured immediately after hemodialysis may not be
good indices of body fluid status in ESRD patients under-
going hemodialysis using a high performance dialyzer.
ProBNP/total BNP may be influenced by hemodialysis vin-
tage, cardiac afterload and diastolic function.
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